PubRank

Andreas Lazar

Author PubWeight™ 33.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Gut 2011 6.08
2 Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology 2011 5.38
3 Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. Gastroenterology 2012 2.03
4 Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A 2005 2.03
5 Pharmacokinetics of clopidogrel after administration of a high loading dose. Thromb Haemost 2004 1.84
6 Cytochrome P450 2C9 phenotyping using low-dose tolbutamide. Eur J Clin Pharmacol 2004 1.58
7 Impact of P-glycoprotein on clopidogrel absorption. Clin Pharmacol Ther 2006 1.57
8 Simultaneous fitting of real-time PCR data with efficiency of amplification modeled as Gaussian function of target fluorescence. BMC Bioinformatics 2008 1.25
9 52-week efficacy of adalimumab in patients with moderately to severely active ulcerative colitis who failed corticosteroids and/or immunosuppressants. Inflamm Bowel Dis 2013 1.16
10 Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children. Gastroenterology 2012 1.07
11 Pharmacogenetics of oral anticoagulants: a basis for dose individualization. Clin Pharmacokinet 2008 1.05
12 Reaction rate constants of superoxide scavenging by plant antioxidants. Free Radic Biol Med 2003 0.95
13 Fast set-up of doxycycline-inducible protein expression in human cell lines with a single plasmid based on Epstein-Barr virus replication and the simple tetracycline repressor. FEBS J 2007 0.88
14 In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans. Cancer Epidemiol Biomarkers Prev 2009 0.85
15 Are organic cation transporters capable of transporting prostaglandins? Naunyn Schmiedebergs Arch Pharmacol 2005 0.83
16 The localisation of the extraneuronal monoamine transporter (EMT) in rat brain. J Neurochem 2004 0.83
17 Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations. Biochem Pharmacol 2007 0.83
18 Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity. Cancer Epidemiol Biomarkers Prev 2006 0.77
19 Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease. Inflamm Bowel Dis 2017 0.75
20 Bronchiolitis in popcorn-factory workers. N Engl J Med 2002 0.75
21 Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease. Inflamm Bowel Dis 2016 0.75
22 The CYP2C9 genotype does not influence sildenafil pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 2005 0.75
23 Rapid detection of the DPYD IVS14+1G>A mutation for screening patients to prevent fluorouracil-related toxicity. Mol Diagn Ther 2007 0.75
24 Detection of a novel 1905C-->T mutation within the dihydropyrimidine dehydrogenase gene and potential for misclassification with the exon 14-skipping mutation. Clin Chem 2003 0.75
25 Association of rheumatoid arthritis with ergothioneine levels in red blood cells: a case control study. J Rheumatol 2006 0.75
26 Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn's Disease. Inflamm Bowel Dis 2017 0.75